MGMT promoter methylation is a rare epigenetic change in malignant effusions.
Marta BrunettiIoannis PanagopoulosFrancesca MicciBen DavidsonPublished in: Cytopathology : official journal of the British Society for Clinical Cytology (2019)
The findings in the present study suggest that MGMT methylation is a rare epigenetic change in malignant effusions of different origin.